highperformr logo

Cara Therapeutics's Overview

Total employees42
HeadquartersStamford
Founded2004

Cara Therapeutics is a commercial-stage biopharmaceutical company committed to developing and commercializing new chemical entities designed to alleviate pruritus (itch) by selectively targeting kappa opioid receptors (KORs). Their lead product, KORSUVA™ (difelikefalin) injection, is the first and only FDA-approved therapy for moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis. They are also developing an oral formulation of difelikefalin for broader indications, including atopic dermatitis and notalgia paresthetica.

Where is Cara Therapeutics's Headquarters?

HQ Function

The Stamford headquarters serves as the central hub for Cara Therapeutics' corporate operations, including executive leadership, research and development oversight, clinical development, regulatory affairs, and commercial strategy.

Notable Features:

The headquarters likely features modern office spaces designed to foster collaboration and innovation, equipped with facilities to support its administrative and R&D management functions.

Work Culture:

As a biopharmaceutical company, the work culture at Cara Therapeutics' headquarters is likely science-driven, patient-focused, and collaborative, emphasizing innovation and regulatory compliance in pursuit of therapeutic advancements.

HQ Significance:

The Stamford headquarters is strategically important for its access to talent, financial markets, and a network of academic and industry collaborators in the Northeast's biotech corridor.

Values Reflected in HQ: The headquarters likely reflects values such as innovation, scientific excellence, integrity, and a commitment to improving patient lives through its operational setup and environment.

Location:

While headquartered in the USA, Cara Therapeutics has a global focus through its clinical trials conducted in multiple countries and its commercial partnership with Vifor Fresenius Medical Care Renal Pharma for KORSUVA™ (difelikefalin) injection outside the U.S. (ex-Japan and South Korea). Their development programs aim to address medical needs worldwide.

Street Address:

107 Elm Street, 9th Floor

City:

Stamford

State/Province:

Connecticut

Country:

USA

Cara Therapeutics's Global Presence

Buying Intent Signals for Cara Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cara Therapeutics

As of April 2025, Cara Therapeutics' leadership includes:

Christopher Posner - President and Chief Executive Officer
Ryan Meadows - Senior Vice President, Chief Financial Officer and Treasurer
Joana Goncalves, M.D. - Chief Medical Officer
Eric Vandal - Senior Vice President, Commercial
Scott Terrillion - Chief Compliance Officer, General Counsel and Corporate Secretary

Investors of Cara Therapeutics

Cara Therapeutics has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
State Street Corporation
NEA Management Company, LLC
Polaris Partners

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits2

Cara Therapeutics has experienced significant executive team changes in the past 12-18 months, including the appointment of a new Chief Financial Officer and a new Chief Medical Officer, alongside the transition of its former Chief Scientific Officer.

Departures

Thomas Reilly, Thomas Reilly departed his role as Chief Financial Officer.
Frederique Menzaghi, Ph.D., Dr. Frederique Menzaghi transitioned from her role as Chief Scientific Officer, continuing as a consultant.

New Appointments:

Ryan Meadows, Ryan Meadows appointed as SVP, CFO, and Treasurer.
Joana Goncalves, M.D., Dr. Joana Goncalves appointed as Chief Medical Officer.

Technology (Tech Stack) used by Cara Therapeutics

Discover the tools Cara Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cara Therapeutics Email Formats and Examples

Cara Therapeutics most likely utilizes a standard corporate email format, commonly [first_initial][last]@caratherapeutics.com. This is a widely adopted pattern for professional communication.

[first_initial][last]@caratherapeutics.com

Format

jdoe@caratherapeutics.com

Example

80%

Success rate

News and media

GlobeNewswireMay 9, 2024

Cara Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Cara Therapeutics announced its financial results for Q1 2024, highlighting revenue from KORSUVA, progress in its oral difelikefalin programs for atopic dermatitis and notalgia paresthetica, and updates on its pipeline development....more

GlobeNewswireApril 18, 2024

Cara Therapeutics Announces Presentations on Oral Difelikefalin at the 2024 American Academy of Dermatology (AAD) Annual Meeting

Cara Therapeutics presented new data and analyses for oral difelikefalin in treating moderate-to-severe pruritus in patients with atopic dermatitis at the AAD Annual Meeting, showcasing its potential efficacy and safety....more

GlobeNewswireJanuary 4, 2024

Cara Therapeutics Appoints Joana Goncalves, M.D. as Chief Medical Officer

Cara Therapeutics announced the appointment of Joana Goncalves, M.D., as its new Chief Medical Officer, effective January 2, 2024. Dr. Goncalves brings extensive experience in clinical development and medical affairs to the company....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cara Therapeutics, are just a search away.